Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Ettlin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Toxicologic Pathology|November 13, 2012
Toxicologic pathology in the 21st centuryRobert A Ettlin
Journal of Toxicologic Pathology|January 25, 2012
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsRobert A Ettlin, Junji Kuroda, Stephanie Plassmann, et al.
Toxicologic Pathology|July 24, 2008
Global recognition of qualified toxicologic pathologists: where we are now and where we need to goRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Journal of Toxicologic Pathology|January 25, 2012
Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical StudiesRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|April 22, 2008
Global recognition of qualified toxicologic pathologists: where we are now and where we need to goRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Toxicologic Pathology|May 22, 2009
Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studiesRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|July 17, 2009
Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studiesRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Journal of Toxicologic Pathology|January 25, 2012
Successful drug development despite adverse preclinical findings part 2: examplesRobert A Ettlin, Junji Kuroda, Stephanie Plassmann, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 21, 2010
International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studiesBrad Bolon, Erio Barale-Thomas, Alys Bradley, et al.
Toxicologic Pathology|August 19, 2010
International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studiesBrad Bolon Chair, Erio Barale-Thomas, Alys Bradley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|November 13, 2012
Toxicologic pathology in the 21st centuryRobert A Ettlin
Journal of Toxicologic Pathology|January 25, 2012
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsRobert A Ettlin, Junji Kuroda, Stephanie Plassmann, et al.
Toxicologic Pathology|July 24, 2008
Global recognition of qualified toxicologic pathologists: where we are now and where we need to goRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Journal of Toxicologic Pathology|January 25, 2012
Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical StudiesRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|April 22, 2008
Global recognition of qualified toxicologic pathologists: where we are now and where we need to goRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Toxicologic Pathology|May 22, 2009
Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studiesRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|July 17, 2009
Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studiesRobert A Ettlin, Brad Bolon, Ian Pyrah, et al.
Journal of Toxicologic Pathology|January 25, 2012
Successful drug development despite adverse preclinical findings part 2: examplesRobert A Ettlin, Junji Kuroda, Stephanie Plassmann, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 21, 2010
International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studiesBrad Bolon, Erio Barale-Thomas, Alys Bradley, et al.
Toxicologic Pathology|August 19, 2010
International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studiesBrad Bolon Chair, Erio Barale-Thomas, Alys Bradley, et al.
Pageof 2